Cyril Allouche serves as Executive at Revance Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Cyril Allouche has executed 14 insider transactions totaling $99.3K, demonstrating a bearish approach to their equity position. Their most recent transaction on Mar 18, 2019 involved selling 498 shares valued at $7.7K.
Cyril Allouche currently holds 6,400 shares of Revance Therapeutics, Inc. (RVNC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Cyril Allouche has been a net seller of RVNC stock. They have purchased $0 and sold $99.3K worth of shares.
Cyril Allouche's most recent insider trade was on Mar 18, 2019, when they sold 498 shares at $15.48 per share.
Get notified when new Form 4 filings are submitted
| $15.45 |
| Discretionary |
| Jan 24, 2019 | RVNC | $0 | Award | 3,150 | $N/A | Discretionary |
| Jan 22, 2019 | RVNC | $11.1K | Sale | 625 | $17.77 | Discretionary |
| Jan 22, 2019 | RVNC | $8.3K | Option Exercise | 625 | $13.35 | Discretionary |
| Jan 3, 2019 | RVNC | $7.3K | Sale | 375 | $19.48 | Discretionary |
| Dec 31, 2018 | RVNC | $6.4K | Other | 375 | $17.11 | Discretionary |
| Nov 20, 2018 | RVNC | $10.1K | Sale | 491 | $20.66 | Discretionary |
| Nov 15, 2018 | RVNC | $5.4K | Payment | 259 | $20.99 | Discretionary |
| Nov 9, 2018 | RVNC | $29.2K | Option Exercise | 2,188 | $13.35 | Discretionary |
| Nov 9, 2018 | RVNC | $51.9K | Sale | 2,188 | $23.72 | Discretionary |
| Jul 6, 2018 | RVNC | $11.1K | Sale | 393 | $28.35 | Discretionary |
| Jun 29, 2018 | RVNC | $9.2K | Other | 393 | $23.33 | Discretionary |
| Jun 20, 2018 | RVNC | $0 | Award | 250 | $N/A | Discretionary |